New study tests if early drug use can stop psoriasis from becoming chronic

NCT ID NCT06742333

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether early use of the drug bimekizumab can delay or prevent chronic inflammation in people with mild plaque psoriasis. 40 adults with recent-onset or long-standing mild psoriasis will receive either bimekizumab injections or a topical steroid cream. The goal is to see if bimekizumab can keep the disease from becoming a long-term problem.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHITS

    RECRUITING

    Toulon, 83000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • CHU Saint-Etienne

    RECRUITING

    Saint-Etienne, 42055, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • CHU de Nice - Hôpital de l'Archet

    RECRUITING

    Nice, Alpes-Maritimes, 06200, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Cabinet Dermatologie Dr RUER

    RECRUITING

    Martigues, 13500, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hôpital Edouard Herriot

    RECRUITING

    Lyon, 69003, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hôpital Saint-Joseph

    RECRUITING

    Marseille, 13005, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Médipole Villeurbanne

    ENROLLING_BY_INVITATION

    Villeurbanne, 69100, France

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.